Webcast: Oncology in APAC - Evaluating the opportunity for novel therapies

In this webcast, Pei Li Teh and Wan Ling Neo, explore the myriad of new therapies in oncology in APAC and address 3 critical business questions which pharmaceutical marketers will need to address in order to demonstrate value to multiple stakeholders and leverage opportunities in the region:

• What will encourage doctors to discuss novel treatments as early as possible rather than reserving efficacious therapies as a last resort?
• What will motivate and influence a patient population to pay for an efficacious high-cost cancer treatment?
• How can brands maximise their return on investment within the short time frame before new entrants come in?

What are the key takeaways?

• The opportunity for novel therapies in Asia 
• Maximising launch opportunity 
• Evaluating value of novel therapies